- Home
- PGEN vs CLCO Comparison
PGEN vs CLCO Comparison
Compare PGEN & CLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- CLCO
- Stock Information
- Founded
- PGEN 1998
- CLCO 2018
- Country
- PGEN United States
- CLCO United Kingdom
- Employees
- PGEN N/A
- CLCO N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- CLCO
- Sector
- PGEN Health Care
- CLCO
- Exchange
- PGEN Nasdaq
- CLCO Nasdaq
- Market Cap
- PGEN 512.5M
- CLCO 340.6M
- IPO Year
- PGEN N/A
- CLCO N/A
- Fundamental
- Price
- PGEN $1.74
- CLCO $5.54
- Analyst Decision
- PGEN Buy
- CLCO
- Analyst Count
- PGEN 5
- CLCO 0
- Target Price
- PGEN $7.00
- CLCO N/A
- AVG Volume (30 Days)
- PGEN 2.0M
- CLCO 352.7K
- Earning Date
- PGEN 05-13-2025
- CLCO 02-27-2025
- Dividend Yield
- PGEN N/A
- CLCO 10.62%
- EPS Growth
- PGEN N/A
- CLCO N/A
- EPS
- PGEN N/A
- CLCO 1.83
- Revenue
- PGEN $3,963,000.00
- CLCO $322,510,000.00
- Revenue This Year
- PGEN N/A
- CLCO $2.52
- Revenue Next Year
- PGEN $420.64
- CLCO N/A
- P/E Ratio
- PGEN N/A
- CLCO $3.09
- Revenue Growth
- PGEN N/A
- CLCO N/A
- 52 Week Low
- PGEN $0.65
- CLCO $4.94
- 52 Week High
- PGEN $2.17
- CLCO $13.68
- Technical
- Relative Strength Index (RSI)
- PGEN 51.69
- CLCO 30.65
- Support Level
- PGEN $1.66
- CLCO $4.94
- Resistance Level
- PGEN $1.95
- CLCO $5.43
- Average True Range (ATR)
- PGEN 0.18
- CLCO 0.31
- MACD
- PGEN -0.03
- CLCO -0.06
- Stochastic Oscillator
- PGEN 30.36
- CLCO 24.39
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About CLCO Cool Company Ltd.
Cool Co Ltd is a LNG shipping company. The company is engaged in the acquisition, ownership, operation and chartering of liquefied natural gas (LNG) carriers (LNGCs), and the operation of third party fleets under management agreements.